W S Industries (I) Limited has informed the Exchange regarding allotment of 9943125 Equity Shares pursuant to Preferential Issue at its meeting held on January 02, 2026

Fund Raising View source PDF Explain this filing

WSI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.5%Reaction day

₹93.35

prior close

₹93.10

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%-1.7% vs market

Civil Construction peers, median of 91sector-1.4%-0.1% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 0.1 pts less than its Civil Construction peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.4

10m

-0.9

15m

-1.2

30m

-1.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.5+0.3-1.7-1.4-0.1

Next day

-4.3-0.4-3.9-2.0-2.3

-1.4-0.4-1.1-2.3+0.8

-3.9-2.3-1.7-4.2+0.2

-7.3-4.0-3.3-5.5-1.8

-8.4-4.8-3.6-6.8-1.6

-10.8-4.5-6.3-7.2-3.6

15d

-15.0-8.0-6.9-11.5-3.5

-13.9-4.2-9.7-9.9-4.0

-26.9-10.2-16.7-17.6-9.3

-15.0-11.8-3.2-20.5+5.4

UpDownMarket · Nifty Microcap 250Sector · Civil Construction peers, median of 91Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

W.S. Industries has allotted 99,43,125 equity shares at ₹100 per share (face value ₹10, premium ₹90), raising about ₹99.43 crore. The shares were issued to two Foreign Portfolio Investors — M7 Global Fund PCC – Cell Dewcap Fund (~49.43 lakh shares) and Vikasa India EIF I Fund (50 lakh shares). Additionally, 50 lakh convertible warrants were allotted to Vikasa India EIF I Fund at ₹100 each (₹50 crore), with 25% upfront and the balance due on conversion within 18 months. M7 Global partially subscribed — 45,56,875 shares offered to it lapsed. The allotments followed shareholder approval on December 12, 2025, and in-principle exchange approvals on December 18, 2025. Total potential capital infusion is around ₹149 crore.

Likely market impact

The company is raising fresh equity capital from reputed foreign investors, which will strengthen its balance sheet and dilute existing shareholders. The steep premium of ₹90 per share signals strong investor confidence, but shareholders should note equity dilution and the potential of further shares from warrant conversion within 18 months.